373 research outputs found

    Organisational routines and interfirm collaboration : measurement dilemmas and recommendations for further research steps

    Get PDF
    Purpose: The paper aims mainly to present the results and consequences of measurement inaccuracies and to make recommendations for further research. Design/Methodology/Approach: We began our research by providing studies on the theoretical origins of constructs in survey questions. Specifically, we studied the theorems and related constructs. We then reviewed the measurement of the constructs, selecting reliable scales. We conducted an initial study on 101 firms in Poland randomly selected from the high-technology sector, specifically the IT sector. We selected an industry in which inter-firm relationships are common. They are distinguished by high innovation, short product and process life cycles and therefor require many relationships to meet customer expectations. The respondents were top managers. The inclusive criterion was their employment of at least five employees. Collected data were analysed with Statistica 13 software (TIBCO Software Inc. (2017). Findings: After solving measurement dilemmas we made methodological recommendations regarding population structure and scales revealing particular constructs. Originality/Value: The implementation of the recommendations aforementioned would allow to formulate and verify hypotheses resulting from the propositions we have formulated while proposing our research framework. Additionally, we obtained a new Propensity to Collaborate scale as the questions referred to particular dimensions joined in quite different groups. Hence, one item has been deleted and the dimensions have been combined. We propose to check the new scale (without dimensions) in the future research.peer-reviewe

    Ethnic differences in ovulatory function in nulliparous women

    Get PDF
    African-American women have a long-standing approximately 20% higher breast cancer incidence rate than USA White women under age 40 while rates among Latinas are lower than those of Whites. The reasons for this are not clear, however they may be due to ethnic differences in circulating oestradiol and progesterone levels. In a cross-sectional study, we investigated whether anovulation frequency and circulating serum oestradiol and/or progesterone levels vary among normally cycling nulliparous African-American (n=60), Latina (n=112) and non-Latina White (n=69) women. Blood and urine specimens were collected over two menstrual cycles among healthy 17- to 34-year-old women. Frequency of anovulation was greater among White women (nine out of 63, 14.3%) than African-American women (four out of 56, 7.1%) or Latina women (seven out of 102, 6.9%), although these differences were not statistically significant. African-American women had 9.9% (P=0.26) higher follicular phase oestradiol concentrations than Latina women and 17.4% (P=0.13) higher levels than White women. African-American women also had considerably higher levels of luteal phase oestradiol (vs Latinas, +9.4%, P=0.14; vs Whites, +25.3%, P=0.003) and progesterone (vs Latinas, +15.4%, P=0.07; vs Whites, +36.4%, P=0.002). Latina women were also observed to have higher follicular oestradiol, and luteal oestradiol and progesterone levels than White women (follicular oestradiol: +6.8%, P=0.48; luteal oestradiol: +14.6%, P=0.04; luteal progesterone: +18.2%, P=0.06). These results suggest that exposure to endogenous steroid hormones may be greater for young African-American and Latina women than for Whites

    The effect of finasteride on the prostate gland in men with elevated serum prostate-specific antigen levels.

    Get PDF
    Prostate cancer is a disease associated with androgens. It has been hypothesized that reducing the conversion of testosterone (T) to dihydrotestosterone (DHT) in the prostate by the use of the drug finasteride, a 5alpha-reductase inhibitor, will reduce the incidence of prostate cancer. We investigated the chemopreventive potential of finasteride by evaluating its effect on the prostate gland of men with elevated serum prostate-specific antigen (PSA). Fifty-two men with elevated PSA and prostate sextant biopsies negative for cancer were randomized to receive finasteride 5 mg day(-1) (27 patients) or no medication (25 patients) for 12 months and were rebiopsied at 12 months. The biopsies were evaluated for the presence of cancer, the proportion of glandular and hyperplastic tissue, and the presence of high-grade prostatic intraepithelial neoplasia (PIN). Epithelial proliferation was assessed in the prestudy and 12-month biopsies by immunohistochemistry using antibody to proliferating cell nuclear antigen (PCNA). Serum blood samples were drawn at baseline and after 1, 3, 6 and 12 months of study. In the control group, serum levels of PSA and T were unchanged throughout the 12 months. In the finasteride group, PSA decreased 48% (P < 0.001), DHT decreased 67% (P < 0.001) and T increased 21% (P < 0.001). Histological evaluation of prestudy and 12-month biopsy specimens revealed that the finasteride group had a 30% reduction in the percentage of hyperplastic epithelial tissue (P = 0.002), although this decrease was not statistically significantly different between the finasteride and control groups (P = 0.11). In patients with PIN on prestudy biopsy, no change occurred in the PIN lesions with finasteride treatment. Finasteride also had no effect on the proliferation index of prostatic epithelial cells. Of the 27 patients treated with finasteride, eight (30%) had adenocarcinoma of the prostate detected on the 12-month biopsy, compared with one (4%) of the control patients (P = 0.025). In the treatment group, six cancers occurred in the eight patients with PIN on the prestudy biopsy; in the observation group no cancers were detected in the five patients with PIN on the prestudy biopsy (P = 0.021). Two cancers occurred in the 19 men in the treatment group with no evidence of PIN on the prestudy biopsy, compared with one cancer in the 20 men in the observation group with no evidence of PIN on the prestudy biopsy (P = 0.60). This study, using a novel model for evaluating short-term efficacy of chemopreventive or therapeutic agents in men at high risk of prostate cancer, provides little evidence that finasteride is an effective chemopreventive agent for prostate cancer in men with elevated PSA

    IGF1 genotype, mean plasma level and breast cancer risk in the Hawaii/Los Angeles multiethnic cohort

    Get PDF
    The insulin-like growth factor 1 gene (IGF1) is a strong candidate gene for a breast cancer susceptibility model. We investigated a dinucleotide repeat 969 bp upstream from the transcription start site of the IGF1 gene for possible associations with plasma IGF1 levels and breast cancer risk in a multiethnic group of postmenopausal women. Furthermore, we investigated the relation between race/ethnicity, mean plasma IGF1 levels and breast cancer rates in the Hawaii/Los Angeles Multiethnic Cohort. The mean age-adjusted IGF1 level among Latino-American women, 116 ng ml(-1), was statistically significantly lower than the mean age-adjusted IGF1 levels for each of the three other racial/ethnic groups, African-American, Japanese-American and Non-Latino White women (146, 144 and 145 ng ml(-1), respectively) (P<0.0001). Latino-American women have the lowest breast cancer rates of any racial/ethnic group in the cohort. These results support the investigation of an expansion of the hypothesis for an important role of IGF1 in breast cancer tumorigenesis to different racial/ethnic groups and to postmenopausal women. It is unlikely that any involvement of IGF1 in breast cancer aetiology is mediated by the IGF1 dinucleotide repeat polymorphism, which was not significantly associated with circulating IGF1 levels nor breast cancer risk in this study. Research into relevant determinants of IGF1 levels in the blood must continue

    Experimental simulations of methane-oriented underground coal gasification using hydrogen - The effect of coal rank and gasification pressure on the hydrogasification process

    Get PDF
    This paper presents a series of surface experimental simulations of methane-oriented underground coal gasification using hydrogen as gasification medium. The main aim of the experiments conducted was to evaluate the feasibility of methane-rich gas production through the in situ coal hydrogasification process. Two multi-day trials were carried out using large scale gasification facilities designed for ex situ experimental simulations of the underground coal gasification (UCG) process. Two different coals were investigated: the “Six Feet” semi-anthracite (Wales) and the “Wesoła" hard coal (Poland). The coal samples were extracted directly from the respective coal seams in the form of large blocks. The gasification tests were conducted in the artificial coal seams (0.41 × 0.41 × 3.05 m) under two distinct pressure regimes - 20 and 40 bar. The series of experiments conducted demonstrated that the physicochemical properties of coal (coal rank) considerably affect the hydrogasification process. For both gasification pressures applied, gas from “Six Feet” semi-anthracite was characterized by a higher content of methane. The average CH4 concentration for “Six Feet” experiment during the H2 stage was 24.12% at 20 bar and 27.03% at 40 bar. During the hydrogasification of “Wesoła" coal, CH4 concentration was 19.28% and 21.71% at 20 and 40 bar, respectively. The process was characterized by high stability and reproducibility of conditions favorable for methane formation in the whole sequence of gasification cycles. Although the feasibility of methane-rich gas production by underground hydrogasification was initially demonstrated, further techno-economic studies are necessary to assess the economic feasibility of methane production using this process

    Surgical resection for persistent seroma, following modified radical mastectomy

    Get PDF
    <p>Abstract</p> <p>Background</p> <p>Seroma formation following modified radical mastectomy with axillary lymph node dissection for breast cancer is a most common wound complication. In our experience seroma occurs in approximately 50% of patients undergoing mastectomy. Postmastectomy seromas usually vanishes within a few weeks after operation.</p> <p>Case presentation</p> <p>In this report we present the case of a 73 year old woman who had undergone mastectomy with axillary lymph node dissection for breast cancer, complicated by lymphorrhea and formation fibrous encapsulated seroma resistant to conservative treatment which required surgical resection.</p> <p>Conclusion</p> <p>We stand in opinion that in some cases of prolonged seromatous effusion with confirmed formation of thick walled reservoir the operation with resection and closure of supplying regional lymph vessels may be the best treatment, if possible preceded by arm lymphoscyntygraphy.</p
    corecore